These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18045178)

  • 41. Guide Needle-Assisted Ablation of Subcapsular Hepatoma with Colonic Interposition (Chilaiditi's Sign).
    Pua U
    Cardiovasc Intervent Radiol; 2016 Apr; 39(4):632-4. PubMed ID: 26486154
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis.
    Salmi A; Turrini R; Lanzani G; Savio A; Anglani L
    Int J Med Sci; 2008; 5(6):327-32. PubMed ID: 18974861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency ablation for treatment of hepatocellular carcinoma with cirrhosis.
    Lo HW; Tsai YJ; Chen PH; Chen HY; Ker CG; Juan CC
    Hepatogastroenterology; 2003; 50(51):645-50. PubMed ID: 12828052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic resection assisted by ablative therapy for advanced hepatocellular carcinoma.
    Hiraoka A; Tazuya N; Hidaka S; Uehara T; Ichiryu M; Nakahara M; Tanabe A; Shimizu Y; Tanihira T; Hasebe A; Miyamoto Y; Ninomiya T; Kawasaki H; Ochi H; Koizumi Y; Hirooka M; Abe M; Hiasa Y; Matsuura B; Onji M; Michitaka K
    Hepatogastroenterology; 2011; 58(107-108):955-9. PubMed ID: 21830423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment options in hepatocellular carcinoma today.
    Livraghi T; Mäkisalo H; Line PD
    Scand J Surg; 2011; 100(1):22-9. PubMed ID: 21482502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival and intra-hepatic recurrences after laparoscopic radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis.
    Santambrogio R; Opocher E; Costa M; Cappellani A; Montorsi M
    J Surg Oncol; 2005 Mar; 89(4):218-25; discussion 225-6. PubMed ID: 15726623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of interventional therapies in hepatocellular carcinoma.
    Lencioni R; Cioni D; Donati F; Bartolozzi C
    Hepatogastroenterology; 2001; 48(37):8-14. PubMed ID: 11269005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?
    Cabibbo G; Antonucci M; Sacco R; Sciarrino E
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):147-50. PubMed ID: 25558787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
    Livraghi T; Meloni F; Di Stasi M; Rolle E; Solbiati L; Tinelli C; Rossi S
    Hepatology; 2008 Jan; 47(1):82-9. PubMed ID: 18008357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
    Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
    Huo TI; Huang YH; Wu JC
    J Chin Med Assoc; 2005 Apr; 68(4):155-9. PubMed ID: 15850062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiofrequency ablation of liver cancer.
    Lencioni R; Crocetti L
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
    Hirashita T; Nakashima K; Sakai M; Sakai I
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimally invasive image-guided therapies for hepatocellular carcinoma.
    Goldberg SN; Ahmed M
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S115-29. PubMed ID: 12394215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical ablation of liver cancer.
    Clark TW
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):58-63. PubMed ID: 17980319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
    Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiofrequency ablation of unresectable primary liver cancer.
    Seidenfeld J; Korn A; Aronson N
    J Am Coll Surg; 2002 Jun; 194(6):813-28; discussion 828. PubMed ID: 12081073
    [No Abstract]   [Full Text] [Related]  

  • 59. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
    Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
    Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The European approach to hepatocellular carcinoma.
    Colombo M; Sangiovanni A
    Hepatogastroenterology; 2002; 49(43):12-6. PubMed ID: 11941934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.